Board of Directors Ballot
Board of Directors Ballot
Slate of Candidates for Fiscal Year 2027
The Official Delegate for each DCAT Member Company is requested to respond to this ballot by Friday, October 23, 2026.
The following slate of candidates has been recommended by the DCAT Leadership Development Committee for the 2027 fiscal year, which begins on November 1, 2026.
EXECUTIVE COMMITTEE, Board of Directors (1 Year Term):
PRESIDENT: Ken Seufert, Chief Executive Officer, JRS Pharma LP
FIRST VICE PRESIDENT: Michael Semo, Associate Vice President, Eli Lilly & Company
SECOND VICE PRESIDENT: Sucheth Davuluri, Executive Vice Chair, Neuland Laboratories LTD
THIRD VICE PRESIDENT: Louis Weber, Vice President of Business Development, Mikart LLC
IMMEDIATE PAST PRESIDENT: Kelsey Achenbach, Vice President, HNC Pharmaceutical Business, dsm-firmenich
DIRECTOR, Board of Directors (1 Year Term):
Allison Vavala, Senior Director, Business Development, Flamma
Athelney Woolnough, Senior Director, Business Development and Key Account Management, Boehringer Ingelheim Biopharmaceuticals GmbH
Matthew Chapas, Senior Director, Program Management, Lonza AG
Stacey Vaughan, Vice President, Marketing & Portfolio Management, West Pharmaceutical Services, Inc.
Syed T. Husain, Chairman & Chief Executive Officer, Made Scientific
Vince Ricevuto, Vice President, R& D, Facilities, Capital & Logistics Procurement, GSK
